{"nct_id":"NCT00220389","title":"Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase","status":"COMPLETED","status_verified_date":"2008-10","start_date":"2003-06","start_date_type":null,"primary_completion_date":"2007-06","primary_completion_date_type":"ACTUAL","completion_date":"2007-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}